Towards a better understanding of heart failure

Dr. Jennifer Van Eyk's ground-breaking research into the protein changes associated with heart failure formed the basis for Cardiomics Inc., a functional proteomics company focused on the identification and characterization of protein markers and targets in cardiovascular disease. Through the assistance of PARTEQ Innovations, a number of Cardiomics technologies for diagnostic and therapeutic approaches to ischemic heart disease continue to be developed by licensee companies.